- •Overall Familial hypercholesterolemia (FH) prevalence in ELSA-Brasil is 1 in 263.
- •From White to Brown to Black Race/Ethnicity, there is increasing FH prevalence.
- •Weighted extrapolation for the Brazilian population derived similar frequencies.
Background and aims
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- National lipid association expert panel on familial H. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the national lipid association expert panel on familial hypercholesterolemia.J Clin Lipidol. 2011; 5: S9-S17
- Familial hypercholesterolemia: a missed opportunity in preventive medicine.Nat. Clin. Pract. Cardiovasc. Med. 2007; 4: 404-405
- Prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in Brasil: baseline of the Brazilian Longitudinal study of adult health (ELSA-Brasil).J Clin Lipidol. 2016; 10: 568-576
- Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.J. Clin. Invest. 1973; 52: 1544-1568
- Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States national health and nutrition examination surveys (NHANES).Circulation. 2016; 133: 1067-1072
- Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.J. Clin. Endocrinol. Metab. 2012; 97: 3956-3964
Resident population and its percentual distribution, according to race/ethnicity and age - Brasil, 1995 to 2015. Applied Economic Research Institute from Statistic and Geography Brazilian Institute.
- Brazilian Longitudinal study of adult health (ELSA-Brasil): objectives and design.Am. J. Epidemiol. 2012; 175: 315-324
- [Routines of organization of clinical tests and interviews in the ELSA-Brasil investigation center].Rev. Saude Publica. 2013; 47: 37-47
- [Logistics of collection and transportation of biological samples and the organization of the central laboratory in the ELSA-Brasil].Rev. Saude Publica. 2013; 47: 63-71
- Familial hypercholesterolemia in a European Mediterranean population-Prevalence and clinical data from 2.5 million primary care patients.J Clin Lipidol. 2017; 11: 1013-1022
- Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis.BMJ open. 2017; 7e016461
- Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brasil.Atherosclerosis. 2017; 263: 257-262
- Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study.Lancet. 2013; 381: 1293-1301
- Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.Eur. Heart J. 2016; 37: 1384-1394
- Statins in familial hypercholesterolemia: consequences for coronary artery disease and all-cause mortality.J. Am. Coll. Cardiol. 2016; 68: 252-260
- Familial hypercholesterolaemia: PCSK9 inhibitors are coming.Lancet. 2015; 385: 307-310
- Evolocumab and clinical outcomes in patients with cardiovascular disease.N. Engl. J. Med. 2017; 376: 1713-1722
- PCSK9 inhibitors and the choice between innovation, efficiency, and affordability.J. Am. Med. Assoc. 2017; 318: 711-712
- Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia.Atherosclerosis. 2016; 254: 73-77